Close Menu

NEW YORK – Agilent Technologies and Oxford BioDynamics (OBD) said on Wednesday that they have signed a supply and resale agreement for the manufacture and sale of OBD's newly launched EpiSwitch Explorer Array Kit.

As part of the agreement, Agilent will supply a custom-made SurePrint G3CGH Microarray for UK-based OBD's research-use-only kit, which will include OBD's 3D Genome Probes. OBD holds exclusive supply and distribution rights for the kit.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.

Nature News writes that viral genomic surveillance in the US faces systemic issues.

President Joe Biden is seeking an increase in federal spending, including higher budgets for the National Institutes of Health and Centers for Disease Control and Prevention.

In PLOS this week: sex-stratified genome-wide association study of chronic pain, sequencing data from Indigenous Mexican groups, and more.